These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24059229)

  • 1. P-glycoprotein and vacuolar ATPase synergistically confer anthracycline resistance to fission yeast and human cells.
    Tay Z; Koo SH; Nguyen TT; Tan TS; Chen ML; Chin CF; Lim KK; Ang WH; Bay BH; Lee EJ; Chen ES
    Curr Med Chem; 2014; 21(2):251-60. PubMed ID: 24059229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simotinib as a modulator of P-glycoprotein: substrate, inhibitor, or inducer?
    Huang L; Shen C; Chen Y; Yan H; Cheng Z; Zhu Q
    Anticancer Drugs; 2016 Apr; 27(4):300-11. PubMed ID: 26766493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium modulation of doxorubicin cytotoxicity in yeast and human cells.
    Nguyen TT; Lim YJ; Fan MH; Jackson RA; Lim KK; Ang WH; Ban KH; Chen ES
    Genes Cells; 2016 Mar; 21(3):226-40. PubMed ID: 26891792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells.
    Gate L; Couvreur P; Nguyen-Ba G; Tapiero H
    Biomed Pharmacother; 2003 Sep; 57(7):301-8. PubMed ID: 14499178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
    Mülder HS; Dekker H; Pinedo HM; Lankelma J
    Biochem Pharmacol; 1995 Sep; 50(7):967-74. PubMed ID: 7575681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of regulators of vacuolar ATPase function and ceramide synthesis results in multidrug sensitivity in Schizosaccharomyces pombe.
    Dawson K; Toone WM; Jones N; Wilkinson CR
    Eukaryot Cell; 2008 Jun; 7(6):926-37. PubMed ID: 18441123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mating of the fission yeast occurs independently of pmd1+ gene product, a structural homologue of budding yeast STE6 and mammalian P-glycoproteins.
    Nishi K; Yoshida M; Horinouchi S; Beppu T
    Arch Microbiol; 1993; 160(2):162-5. PubMed ID: 8104396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
    Loo TW; Clarke DM
    Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein.
    Marbeuf-Gueye C; Ettori D; Priebe W; Kozlowski H; Garnier-Suillerot A
    Biochim Biophys Acta; 1999 Jul; 1450(3):374-84. PubMed ID: 10395948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
    Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
    Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin reverses doxorubicin resistance via inhibition the efflux function of ABCB4 in doxorubicin‑resistant breast cancer cells.
    Wen C; Fu L; Huang J; Dai Y; Wang B; Xu G; Wu L; Zhou H
    Mol Med Rep; 2019 Jun; 19(6):5162-5168. PubMed ID: 31059026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.
    Jonsson O; Behnam-Motlagh P; Persson M; Henriksson R; Grankvist K
    Biochem Pharmacol; 1999 Dec; 58(11):1801-6. PubMed ID: 10571255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.
    Zhu HJ; Wang JS; Guo QL; Jiang Y; Liu GQ
    Biol Pharm Bull; 2005 Oct; 28(10):1974-8. PubMed ID: 16204958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
    Garrigos M; Mir LM; Orlowski S
    Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
    Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
    Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cabazitaxel is more active than first-generation taxanes in ABCB1(+) cell lines due to its reduced affinity for P-glycoprotein.
    Duran GE; Derdau V; Weitz D; Philippe N; Blankenstein J; Atzrodt J; Sémiond D; Gianolio DA; Macé S; Sikic BI
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1095-1103. PubMed ID: 29675746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ailanthone reverses multidrug resistance by inhibiting the P-glycoprotein-mediated efflux in resistant K562/A02 cells.
    Han F; Liu G; Sun C; Wei J
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):55-61. PubMed ID: 30672437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.